Voyageur Pharmaceuticals (CVE:VM) Trading 50% Higher – Should You Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shares were up 50% during trading on Wednesday . The stock traded as high as C$0.11 and last traded at C$0.11. Approximately 1,942,446 shares changed hands during mid-day trading, an increase of 1,795% from the average daily volume of 102,479 shares. The stock had previously closed at C$0.07.

Voyageur Pharmaceuticals Price Performance

The business’s 50-day simple moving average is C$0.07 and its 200 day simple moving average is C$0.06. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The company has a market capitalization of C$13.95 million, a P/E ratio of -10.00 and a beta of 0.32.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Read More

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.